User menu

Immunogenic (tum-) Variants Obtained By Mutagenesis of Mouse Mastocytoma-p815 .8. Detection of Stable Transfectants Expressing a Tum- Antigen With a Cytolytic T-cell Stimulation Assay

Bibliographic reference Wolfel, T. ; Van Pel, Aline ; De Plaen, Etienne ; Lurquin, C. ; Maryanski, JL. ; et. al. Immunogenic (tum-) Variants Obtained By Mutagenesis of Mouse Mastocytoma-p815 .8. Detection of Stable Transfectants Expressing a Tum- Antigen With a Cytolytic T-cell Stimulation Assay. In: Immunogenetics, Vol. 26, no. 3, p. 178-187 (1987)
Permanent URL http://hdl.handle.net/2078.1/53694
  1. Albino, A. P., Graff, L. H., Kantor, R. R., McLean, W., Silagi, S., and Old, L. J.: DNA-mediated transfer of human melanoma cell surface glycoprotein gp130: Identification of transfectants by erythrocyte rosetting. Mol. Cell. Biol. 5: 692?697, 1985
  2. Bernard, H.-U., Krämmer, G., and Röwekamp, W. G.: Construction of a fusion gene that confers resistance against Hygromycin B to mammalian cells in culture. Exp. Cell Res. 158: 237?243, 1985
  3. Boon, T.: Antigenic tumor cell variants obtained with mutagens. Adv. Cancer Res. 39: 121?151, 1983
  4. Boon, T. and Kellermann, O.: Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc. Natl. Acad. Sci. U.S.A. 74: 272?275, 1977
  5. Boon, T., Van Snick, J., Van Pel, A., Uyttenhove, C., and Marchand, M.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. Lymphocyte-mediated cytolysis. J. Exp. Med. 152: 1184?1193, 1980
  6. Brady, G., Funk, A., Mattern, J., Schütz, G., and Brown, R.: Use of gene transfer and a novel cosmid rescue strategy to isolate transforming sequences. EMBO J. 4: 2583?2588, 1985
  7. Chang, A. C. Y. and Cohen, S. N.: Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134: 1141?1166, 1978
  8. Corsaro, C. M. and Pearson, M. L.: Enhancing the efficiency of DNAmediated gene transfer in mammalian cells. Somatic Cell Genet. 7: 603?616, 1981
  9. Davis, R. W., Botstein, D., and Roth, J. R.: A Manual for Genetic Engineering. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1980
  10. Frost, P., Kerbel, R. S., Bauer, E., Tartamella-Biondo, R., and Cefalu, W.: Mutagen treatments as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res. 43: 125?132, 1983
  11. Frost, P., Liteplo, R. G., Donaghue, T. P., and Kerbel, R. S.: Selection of strongly immunogenic ?tum?? variants from tumors at high frequency using 5-azacytidine. J. Exp. Med. 159: 1491?1501, 1984
  12. Graff, R. C.: Minor histocompatibility genes and their antigens. Transplant. Proc. 10: 701?705, 1978
  13. Graham, F. L. and Van der Eb, A. J.: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456?467, 1973
  14. Heidman, O. and Rougeon, F.: Multiple sequences related to a constantregion kappa light chain gene in the rabbit genome. Cell 28: 507?513, 1982
  15. Hérin, M., Lemoine, C., Weynants, P., Vessière, F., Van Pel, A., Knuth, A., Devos, R., and Boon, T.: Production of stable cytolytic T cell clones directed against autologous human melanoma. Int. J. Cancer 39: 390?396, 1987
  16. Kavathas, P. and Herzenberg, L. A.: Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and ? 2-microglobulin: Selection by fluorescence-activated cell sorting. Proc. Natl. Acad. Sci. U.S.A. 80: 524?528, 1983
  17. Kerbel, R. S., Waghorne, C., Man, M. S., Elliott, B., and Breitman, M. L.: Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphatemediated DNA transfection. Proc. Natl. Acad. Sci. U.S.A. 84: 1263?1267, 1987
  18. Klein, J.: H-2 mutations: Their genetics and effect on immune functions. Adv. Immunol. 26: 56?145, 1978
  19. Kühn, L. C., McClelland, A., and Ruddle, F. H.: Gene transfer, expression, and molecular cloning of the human transferrin receptor gene. Cell 37: 95?103, 1984
  20. Lambotte, P., Van Snick, J., and Boon, T.: Partial purification of a membrane glycoprotein antigen by high-pressure size-exclusion chromatography without loss of antigenicity. J. Chromatogr. 297: 139?145, 1984
  21. Lebkowski, J. S., DuBridge, R. B., Antell, E. A., Geisen, K. S., and Calos, M. P.: Transfected DNA is mutated in monkey, mouse and human cells. Mol. Cell. Biol. 4: 1951?1960, 1984
  22. Littman, D. R., Thomas, Y., Maddon, P. J., Chess, L., and Axel, R.: The isolation and sequence of the gene encoding T8: A molecule defining functional classes of T lymphocytes. Cell 40: 237?246, 1985
  23. Loveland, B. and Simpson, E.: The non-MHC transplantation antigens: Neither weak nor minor. Immunol. Today 7: 223?229, 1986
  24. Maniatis, T., Fritsch, E., and Sambrook, J.: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982
  25. Maryanski, J. L. and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variantspecific antigens by selection of antigen-loss variants with cytolytic T cell clones. Eur. J. Immunol. 12: 406?412, 1982
  26. Maryanski, J. L., Van Snick, J., Cerottini, J.-C., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. Eur. J. Immunol. 12: 401?406, 1982
  27. Maryanski, J. L., Marchand, M., Uyttenhove, C., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigenloss secondary variants. Int. J. Cancer 31: 119?123, 1983a
  28. Maryanski, J. L., Szpirer, J., Szpirer, C., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids. Somatic Cell Genet. 9: 345?357, 1983b
  29. Nicolas, J. F. and Berg, P.: Regulation of expression of genes transduced into embryonal carcinoma cells. Cold Spring Harbor Conferences Cell Prolif. 10: 469?485, 1983
  30. Perucho, M., Hanahan, D., and Wigler, M.: Genetic and physical linkage of exogenous sequences in transformed cells. Cell 22: 309?317, 1980a
  31. Perucho, M., Hanahan, D., Lipsich, L., and Wigler, M.: Isolation of the chicken thymidine kinase gene by plasmid rescue. Nature 285: 207?210, 1980b
  32. Ryser, J. E., Cerottini, J.-C., and Brunner, K. T.: Generation of cytolytic T lymphocytes in vitro. IX. Induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC. J. Immunol. 120: 370?377, 1978
  33. Santos, E., Premkumar Reddy, E., Pulciani, S., Feldmann, R. J., and Barbacid, M.: Spontaneous activation of a human proto-oncogene. Proc. Natl. Acad. Sci. U.S.A. 80: 4679?4683, 1983
  34. Scangos, G. and Ruddle, R.: Mechanisms and applications of DNAmediated gene transfer in mammalian cells ? a review. Gene 14: 1?10, 1981
  35. Seed, B.: Purification of genomic sequences from bacteriophage libraries by recombination and selection in vivo. Nucleic Acids Res. 11: 2427?2445, 1983
  36. Simpson, E.: The role of H-Y as a minor transplantation antigen. Immunol. Today 3: 97?106, 1982
  37. Stein, R., Razin, A., and Cedar, H.: In vitro methylation of the hamster adenine phosphoribosyltransferase gene inhibits its expression in mouse L cells. Proc. Natl. Acad. Sci. U.S.A. 79: 3418?3422, 1982
  38. Uyttenhove, C., Van Snick, J., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J. Exp. Med. 152: 1175?1183, 1980
  39. Van Pel, A., Georlette, M., and Boon, T.: Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: Immune rejection by syngeneic mice. Proc. Natl. Acad. Sci. U.S.A. 76: 5282?5285, 1979
  40. Van Pel, A., Vessière, F., and Boon, T.: Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. J. Exp. Med. 157: 1992?2001, 1983
  41. Van Pel, A., De Plaen, E., and Boon, T.: Selection of highly transfectable variant from mouse mastocytoma P815. Somatic Cell Genet. 11: 467?475, 1985
  42. Van Snick, J., Uyttenhove, C., Van Pel, A., and Boon, T.: Stimulation of cytolytic T lymphocytes by azaguanine-resistant mouse tumor cells in selective HAT medium. J. Immunol. Methods 46: 321?326, 1981
  43. Van Snick, J., Maryanski, J. L., Van Pel, A., Parmiani, G., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens. Eur. J. Immunol. 12: 905?908, 1982
  44. Wigler, M., Pellicer, A., Silverstein, S., and Axel, R.: Biochemical transfer of single-copy eukaryotic genes using total cellular DNA as donor. Cell 14: 725?731, 1978
  45. Zinkernagel, R. M. and Doherty, P. C.: Restriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701?702, 1974